DexCom Inc.

NASDAQ: DXCM · Real-Time Price · USD
80.94
0.98 (1.23%)
At close: Aug 15, 2025, 3:59 PM
80.80
-0.17%
After-hours: Aug 15, 2025, 07:51 PM EDT

DexCom Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
576.2M 541.5M 341.2M 154.7M
Depreciation & Amortization
217.7M 186M 155.9M 102M
Stock-Based Compensation
170.4M 150.8M 126.5M 113.4M
Other Working Capital
-80.3M 49.4M -116.8M -2.3M
Other Non-Cash Items
-39.8M -78M 39.8M 209.3M
Deferred Income Tax
-43.8M -55M -21.6M -4.9M
Change in Working Capital
108.8M 3.2M 27.7M -132M
Operating Cash Flow
989.5M 748.5M 669.5M 442.5M
Capital Expenditures
-358.8M -236.6M -364.8M -389.2M
Cash Acquisitions
n/a n/a -3.9M -30.2M
Purchase of Investments
-2.66B -3.2B -2.27B -2.47B
Sales Maturities Of Investments
2.82B 2.95B 2.13B 2.67B
Other Investing Acitivies
-15.5M -17.6M -14.3M 10.1M
Investing Cash Flow
-207.5M -507.2M -521.5M -216.1M
Debt Repayment
n/a 443.3M n/a n/a
Common Stock Repurchased
-750M -688.7M -557.7M n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-13M -99.8M -17.3M -9.9M
Financial Cash Flow
-734.8M -318.6M -552.5M 10.4M
Net Cash Flow
39.8M -75.8M -410.3M 235.4M
Free Cash Flow
630.7M 511.9M 304.7M 53.3M